PL3253743T3 - Syntetyczny sposób otrzymywania pochodnych kwasu 2-furanokarboksylowego - Google Patents
Syntetyczny sposób otrzymywania pochodnych kwasu 2-furanokarboksylowegoInfo
- Publication number
- PL3253743T3 PL3253743T3 PL16706095T PL16706095T PL3253743T3 PL 3253743 T3 PL3253743 T3 PL 3253743T3 PL 16706095 T PL16706095 T PL 16706095T PL 16706095 T PL16706095 T PL 16706095T PL 3253743 T3 PL3253743 T3 PL 3253743T3
- Authority
- PL
- Poland
- Prior art keywords
- preparing
- acid derivatives
- synthetic process
- furoic acid
- furoic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Furan Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562112519P | 2015-02-05 | 2015-02-05 | |
PCT/US2016/016619 WO2016126975A1 (en) | 2015-02-05 | 2016-02-04 | Synthetic process for preparing 2-furoic acid derivatives |
EP16706095.3A EP3253743B1 (en) | 2015-02-05 | 2016-02-04 | Synthetic process for preparing 2-furoic acid derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
PL3253743T3 true PL3253743T3 (pl) | 2020-03-31 |
PL3253743T4 PL3253743T4 (pl) | 2020-03-31 |
Family
ID=55410252
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL16706095T PL3253743T4 (pl) | 2015-02-05 | 2016-02-04 | Syntetyczny sposób otrzymywania pochodnych kwasu 2-furanokarboksylowego |
Country Status (13)
Country | Link |
---|---|
US (1) | US9975867B2 (pl) |
EP (1) | EP3253743B1 (pl) |
JP (1) | JP6726670B2 (pl) |
KR (1) | KR20170115065A (pl) |
CN (1) | CN107567441A (pl) |
AU (1) | AU2016215230A1 (pl) |
CA (1) | CA2975922A1 (pl) |
DK (1) | DK3253743T3 (pl) |
ES (1) | ES2742412T3 (pl) |
HK (1) | HK1243708A1 (pl) |
PL (1) | PL3253743T4 (pl) |
PT (1) | PT3253743T (pl) |
WO (1) | WO2016126975A1 (pl) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10544118B2 (en) | 2018-06-25 | 2020-01-28 | Eastman Chemical Company | Oxidation process to produce 5 methyl 5-methylfuran-2-carboxylate (MMFC) |
US11440895B2 (en) | 2018-06-25 | 2022-09-13 | Eastman Chemical Company | Oxidation process to produce 5-(alkoxycarbonyl)furan-2-carboxylic acids (ACFC) |
US11655334B2 (en) | 2018-06-25 | 2023-05-23 | Eastman Chemical Company | Oxidation process to produce 5 methyl 5-methylfuran-2-carboxylate (MMFC) |
US11787774B2 (en) | 2019-09-05 | 2023-10-17 | Eastman Chemical Company | Efficient process for producing 5-(alkoxycarbonyl)-furan-2-carboxylic acids |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4110351A (en) | 1973-04-02 | 1978-08-29 | Richardson-Merrell Inc. | Hypolipidemic agents RO- or RS- substituted furoic acids, esters and salts |
DE4033563A1 (de) | 1990-10-22 | 1992-04-23 | Henkel Kgaa | Antiseborrhoische zubereitungen |
US20100204317A1 (en) | 2006-11-03 | 2010-08-12 | Qlt Inc. | Methods of treating dermatological disorders or conditions |
WO2011005660A1 (en) * | 2009-07-08 | 2011-01-13 | Valocor Therapeutics, Inc. | Tofa analogs useful in treating dermatological disorders or conditions |
-
2016
- 2016-02-04 ES ES16706095T patent/ES2742412T3/es active Active
- 2016-02-04 AU AU2016215230A patent/AU2016215230A1/en not_active Abandoned
- 2016-02-04 CA CA2975922A patent/CA2975922A1/en not_active Abandoned
- 2016-02-04 DK DK16706095.3T patent/DK3253743T3/da active
- 2016-02-04 PT PT16706095T patent/PT3253743T/pt unknown
- 2016-02-04 US US15/015,569 patent/US9975867B2/en not_active Expired - Fee Related
- 2016-02-04 PL PL16706095T patent/PL3253743T4/pl unknown
- 2016-02-04 CN CN201680008917.3A patent/CN107567441A/zh active Pending
- 2016-02-04 EP EP16706095.3A patent/EP3253743B1/en active Active
- 2016-02-04 JP JP2017541702A patent/JP6726670B2/ja not_active Expired - Fee Related
- 2016-02-04 KR KR1020177023579A patent/KR20170115065A/ko unknown
- 2016-02-04 WO PCT/US2016/016619 patent/WO2016126975A1/en active Application Filing
-
2018
- 2018-03-08 HK HK18103282.1A patent/HK1243708A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
ES2742412T3 (es) | 2020-02-14 |
PT3253743T (pt) | 2019-09-04 |
HK1243708A1 (zh) | 2018-07-20 |
CN107567441A (zh) | 2018-01-09 |
WO2016126975A1 (en) | 2016-08-11 |
JP6726670B2 (ja) | 2020-07-22 |
KR20170115065A (ko) | 2017-10-16 |
DK3253743T3 (da) | 2019-08-19 |
US20160229825A1 (en) | 2016-08-11 |
CA2975922A1 (en) | 2016-08-11 |
EP3253743B1 (en) | 2019-05-15 |
AU2016215230A1 (en) | 2017-08-10 |
EP3253743A1 (en) | 2017-12-13 |
JP2018505891A (ja) | 2018-03-01 |
US9975867B2 (en) | 2018-05-22 |
PL3253743T4 (pl) | 2020-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA201708142B (en) | Process for preparing 4-amino-pyridazines | |
PL3325443T3 (pl) | Sposób otrzymywania pridopidyny | |
GB201509854D0 (en) | Process for preparing mesotrione | |
IL274439A (en) | Process for making Tapinaroff | |
HUE053818T2 (hu) | Eljárás HMF elõállítására | |
GB2531940B (en) | Process for preparing methotrexate formulation | |
IL253877B (en) | Process for the preparation of 3-chloro-2-vinylphenylsulfonates | |
HK1245792A1 (zh) | 製備α-甲酰胺吡咯烷衍生物的方法 | |
HK1255014A1 (zh) | 製備取代5,6-二氫-6-苯基苯並[f]異喹啉-2-胺的方法 | |
HK1243708A1 (zh) | 用於製備2-糠酸衍生物的合成方法 | |
PT3166923T (pt) | Processo para preparar fenilalcanos substituídos | |
PL3160984T3 (pl) | Sposób wytwarzania d-arginylo-2,6-dimetylo-l-tyrozylo-l-lizylol- fenyloalaninoamidu | |
ZA201801650B (en) | Process for producing novel 4-benzoazonine derivatives | |
IL248568A0 (en) | A process for the preparation of dihydroisoxazole derivatives | |
ZA201908452B (en) | Improved process for preparing imetelstat | |
GB2561089B (en) | Process for the preparation of 17beta-hydroxy-des-a-androst-9, 10-en-5-one | |
IL249283B (en) | Process for the preparation of 3-chloro-2-vinylphenol | |
IL253630B (en) | A process for the preparation of modified phenylisoxazoline derivatives | |
ZA201807441B (en) | Process for preparing oxathiazin-like compounds | |
IL253830B (en) | Process for the preparation of piperidine-4-carbothioamide hydrochloride | |
GB201414880D0 (en) | Process for making phosphate derivatives | |
HUP1500034A1 (en) | Process for the preparation of vortioxetine salts |